Viewing Study NCT01227603


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2025-12-29 @ 11:01 PM
Study NCT ID: NCT01227603
Status: COMPLETED
Last Update Posted: 2015-12-10
First Post: 2010-10-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Dose Bioequivalence Study Comparing Nifedipine/Candesartan FDC (Fixed Dose Combination) With Loose Combination of Nifedipine GITS (Gastro-intestinal Therapeutic System) Plus Candesartan and Single Components Under Fasting Conditions
Sponsor: Bayer
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 14027
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators